The tumor necrosis factor α -308 G/A polymorphism does not influence inflammation and coagulation response in human endotoxemia

Shock

Volumn 27, Issue 3, 2007, Pages 238-241

  Kovar, Florian M ^a   Marsik, Claudia ^a   Cvitko, Tuende ^a   Wagner, Oswald F ^a   Jilma, Bernd ^a,b   Endler, Georg ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE   (Austria)

Author keywords

308 G A polymorphism; Cytokines; Endotoxin; Human; Inflammation; TNF

Indexed keywords

ENDOTOXIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTHROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; ENDOTOXEMIA; GENOMICS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPERATURE MEASUREMENT;

ADULT; BLOOD COAGULATION; CYTOKINES; ENDOTOXEMIA; ENDOTOXINS; GENOTYPE; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847039081     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000239768.64786.3a     Document Type: Article

References (44)

1. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riche F, et al.: Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561-568, 1999.
2. Chow CC, Clermont G, Kumar R, Lagoa C, Tawadrous Z, Gallo D, Betten B, Bartels J, Constantine G, Fink MP, et al.: The acute inflammatory response in diverse shock states. Shock 24:74-84, 2005.
3. Lin WJ, Yeh WC: Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock. Shock 24:206-209, 2005.
4. van der Poll T, Calvano SE, Kumar A, Braxton CC, Coyle SM, Barbosa K, Moldawer LL, Lowry SF: Endotoxin induces downregulation of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans. Blood 86:2754-2759, 1995.
5. Hoesel LM, Neff TA, Neff SB, Younger JG, Olle EW, Gao H, Pianko MJ, Bernacki KD, Sarma JV, Ward PA: Harmful and protective roles of neutrophils in sepsis. Shock 24:40-47, 2005.
6. Iba T, Kidokoro A, Fukunaga M, Sugiyama K, Sawada T, Kato H: Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers. Shock 23:25-29, 2005.
7. Riese J, Schoolmann S, Denzel C, Herrmann O, Hohenberger W, Haupt W: Effect of abdominal infections on peritoneal and systemic production of interleukin 6 and monocyte chemoattractant protein-1. Shock 17:361-364, 2002.
8. Heesen M, Kunz D, Bachmann-Mennenga B, Merk HF, Bloemeke B: Linkage disequilibrium between tumor necrosis factor (TNF)-alpha -308 G/A promoter and TNF-beta NcoI polymorphisms: association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit Care Med 31:211-214, 2003.
9. Schippers EF, van't Veer C, van Voorden S, Martina CA, le Cessie S, van Dissel JT: NF-alpha promoter, Nod2 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 26:16-24, 2004.
10. Heesen M, Kunz D, Wessiepe M, van der Poll T, Zwinderman AH, Blomeke B: Rapid genotyping for tumor necrosis factor-alpha (TNF-alpha)-863C/A promoter polymorphism that determines TNF-alpha response. Clin Chem 50:226-228, 2004.
11. Riese J, Woerner K, Zimmermann P, Denzel C, Hohenberger W, Haupt W: Association of a TNFbeta gene polymorphism with complications after major abdominal operations. Shock 19:1-4, 2003.
12. Lee YH, Harley JB, Nath SK: Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 14:364-371, 2006.
13. Gupta V, Sarin BC, Changotra H, Sehajpal PK: Association of G-308A TNF-alpha polymorphism with bronchial asthma in a North Indian population. J Asthma 42:839-841, 2005.
14. Li JJ, Fang CH: C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses 62:499-506, 2004.
15. Aguillon JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M: Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution? Immunobiology 211:75-84, 2006.
16. Sallakci N, Akcurin G, Koksoy S, Kardelen F, Uguz A, Coskun M, Ertug H, Yegin O: TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production. J Autoimmun 25:150-154, 2005.
17. Sookoian SC, Gonzalez C, Pirola CJ: Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. Obes Res 13:2122-2131, 2005.
18. Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW: TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 41:808-813, 2004.
19. Hedberg CL, Adcock K, Martin J, Loggins J, Kruger TE, Baier RJ: Tumor necrosis factor alpha -308 polymorphism associated with increased sepsis mortality in ventilated very low birth weight infants. Pediatr Infect Dis J 23:424-428, 2004.
20. Sipahi T, Pocan H, Akar N: Effect of various genetic polymorphisms on the incidence and outcome of severe sepsis. Clin Appl Thromb Hemost 12:47-54, 2006.
21. Watanabe E, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, Abe R, Nakada T: Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications. J Trauma 59:1181-1189, 2005. [discussion 1189-1190, 2005].
22. Waterer GW, Quasney MW, Cantor RM, Wunderink RG: Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 163:1599-1604, 2001.
23. Gordon AC, Lagan AL, Aganna E, Cheung L, Peters CJ, McDermott MF, Millo JL, Welsh KI, Holloway P, Hitman GA, et al.: TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study. Genes Immun 5:631-640, 2004.
24. Marshall JC, Deitch E, Moldawer LL, Opal S, Redl H, van der Poll T: Preclinical models of shock and sepsis: what can they tell us? Shock 24(suppl 1):1-6, 2005.
25. Marsik C, Jilma B, Joukhadar C, Mannhalter C, Wagner O, Endler G: The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. Clin Chem 51:2178-2180, 2005.
26. Derhaschnig U, Pachinger C, Schweeger-Exeli I, Marsik C, Jilma B: Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemia. Thromb Haemost 90:1054-1060, 2003.
27. Jilma B, Marsik C, Kovar F, Wagner OF, Jilma-Stohlawetz P, Endler G: The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia. Blood 105:2380-2383, 2005.
28. Marsik C, Halama T, Cardona F, Wlassits W, Mayr F, Pleiner J, Jilma B: Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humans. Shock 20:493-496, 2003.
29. Marsik C, Endler G, Halama T, Schlifke I, Mustafa S, Hysjulien JL, Key NS, Jilma B: Polymorphism in the tissue factor region is associated with basal but neither endotoxin-induced TF-mRNA levels in leukocytes nor LPS-induced coagulation in humans. J Thromb Haemost 4:745-749, 2006.
30. Derhaschnig U, Bergmair D, Marsik C, Schlifke I, Wijdenes J, Jilma B: Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia. Crit Care Med 32:1136-1140, 2004.
31. Derhaschnig U, Reiter R, Knobl P, Baumgartner M, Keen P, Jilma B: Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. Blood 102:2093-2098, 2003.
32. Joseph L, Wolfson DB, Du Berger R: Sample size calculations for binomial proportions via highest posterior density intervals. Statistician 44:143-154, 1995.
33. Wenzel RP, Pinsky MR, Ulevitch RJ, Young L: Current understanding of sepsis. Clin Infect Dis 22:407-412, 1996.
34. Wheeler AP, Bernard GR: Treating patients with severe sepsis. N Engl J Med 340:207-214, 1999.
35. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195-3199, 1997.
36. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, et al.: Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113:401-406, 1998.
37. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL: Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 46:32-41, 1995.
38. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486, 1988.
39. Stuber F, Petersen M, Bokelmann F, Schade U: A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24:381-384, 1996.
40. Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A: Genetic influence on cytokine production in meningococcal disease. Lancet 349:1912-1913, 1997.
41. Temple SE, Cheong KY, Almeida CM, Price P, Waterer GW: Polymorphisms in lymphotoxin alpha and CD14 genes influence TNFalpha production induced by Gram-positive and Gram-negative bacteria. Genes Immun 4:283-288, 2003.
42. Nedospasov SA, Hirt B, Shakhov AN, Dobrynin VN, Kawashima E, Accolla RS, Jongeneel CV: The genes for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) are tandemly arranged on chromosome 17 of the mouse. Nucleic Acids Res 14:7713-7725, 1986.
43. Trowsdale J: Genomic structure and function in the MHC. Trends Genet 9:117-122, 1993.
44. Pociot F, Wilson AG, Nerup J, Duff GW: No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 23:3050-3053, 1993.